ECSP003859A - Composicion para el tratamiento de tejidos dañados - Google Patents
Composicion para el tratamiento de tejidos dañadosInfo
- Publication number
- ECSP003859A ECSP003859A EC2000003859A ECSP003859A ECSP003859A EC SP003859 A ECSP003859 A EC SP003859A EC 2000003859 A EC2000003859 A EC 2000003859A EC SP003859 A ECSP003859 A EC SP003859A EC SP003859 A ECSP003859 A EC SP003859A
- Authority
- EC
- Ecuador
- Prior art keywords
- treatment
- composition
- damaged
- wound
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Agente farmacéutico para uso en el tratamiento (por ejemplo, curación) de tejidos danados, tal como una herida, comprendiendo el agente farmacéutico una composición que comprende: (a) un factor de crecimiento;(b) un agente inhibidor;y, opcionalmente, (c) un vehículo, diluyente o excipiente farmaceúticamente aceptable;pudiendo el agente inhibidor inhibir la acción de al menos una proteína adversa específica (por ejemplo, una proteasa específica) que está regulada positivamente en un entorno de tejido danado, tal como una herida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9930768.8A GB9930768D0 (en) | 1999-12-29 | 1999-12-29 | Composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP003859A true ECSP003859A (es) | 2002-09-27 |
Family
ID=10867127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2000003859A ECSP003859A (es) | 1999-12-29 | 2000-12-28 | Composicion para el tratamiento de tejidos dañados |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1242120A2 (es) |
JP (1) | JP2003519193A (es) |
AR (1) | AR027122A1 (es) |
AU (1) | AU1878201A (es) |
CA (1) | CA2395487A1 (es) |
CO (1) | CO5271671A1 (es) |
EC (1) | ECSP003859A (es) |
GB (1) | GB9930768D0 (es) |
GT (1) | GT200000224A (es) |
PE (1) | PE20011095A1 (es) |
UY (1) | UY26514A1 (es) |
WO (1) | WO2001049309A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
ES2304401T3 (es) | 2000-10-16 | 2008-10-16 | Genentech, Inc. | Metodos de tratamiento que utilizan polipeptidos wisp. |
DK1414487T3 (da) | 2001-07-27 | 2006-10-09 | Orthologic Corp | Anvendelse af thrombin-peptidderivater til behandling af kroniske hudsår |
WO2003029819A1 (fr) * | 2001-09-28 | 2003-04-10 | Takeda Chemical Industries, Ltd. | Procede pour le criblage preventif / le traitement des maladies d'os ou d'articulations |
JP2006514822A (ja) | 2002-07-02 | 2006-05-18 | ザ ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム | トロンビンペプチド誘導体 |
ATE357928T1 (de) | 2003-12-31 | 2007-04-15 | Orthologic Corp | Pharmazeutische zusammensetzung für thrombinpeptidderivaten |
ES2370040T3 (es) | 2005-10-07 | 2011-12-12 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.R.L. | Vacuna de metaloproteinasa 11 de la matriz. |
CN101965193A (zh) * | 2006-11-15 | 2011-02-02 | 科达治疗公司 | 用于伤口愈合的改进方法和组合物 |
KR101629504B1 (ko) * | 2014-04-14 | 2016-06-10 | 주식회사 엘지생활건강 | 사이토카인 조합을 함유하는 피부 상태 개선용 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01279840A (ja) * | 1988-04-28 | 1989-11-10 | Wakunaga Pharmaceut Co Ltd | 新規外用組成物 |
GB9405076D0 (en) * | 1994-03-16 | 1994-04-27 | Inst Of Ophtalmology | A medical use of matrix metalloproteinase inhibitors |
-
1999
- 1999-12-29 GB GBGB9930768.8A patent/GB9930768D0/en not_active Ceased
-
2000
- 2000-12-21 CA CA002395487A patent/CA2395487A1/en not_active Abandoned
- 2000-12-21 AU AU18782/01A patent/AU1878201A/en not_active Abandoned
- 2000-12-21 WO PCT/IB2000/001935 patent/WO2001049309A2/en not_active Application Discontinuation
- 2000-12-21 CO CO00097188A patent/CO5271671A1/es not_active Application Discontinuation
- 2000-12-21 EP EP00981550A patent/EP1242120A2/en not_active Withdrawn
- 2000-12-21 JP JP2001549676A patent/JP2003519193A/ja not_active Withdrawn
- 2000-12-22 GT GT200000224A patent/GT200000224A/es unknown
- 2000-12-27 AR ARP000106960A patent/AR027122A1/es not_active Application Discontinuation
- 2000-12-27 PE PE2000001405A patent/PE20011095A1/es not_active Application Discontinuation
- 2000-12-28 UY UY26514A patent/UY26514A1/es not_active Application Discontinuation
- 2000-12-28 EC EC2000003859A patent/ECSP003859A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2395487A1 (en) | 2001-07-12 |
AU1878201A (en) | 2001-07-16 |
GT200000224A (es) | 2002-06-15 |
PE20011095A1 (es) | 2001-10-27 |
EP1242120A2 (en) | 2002-09-25 |
GB9930768D0 (en) | 2000-02-16 |
UY26514A1 (es) | 2001-07-31 |
JP2003519193A (ja) | 2003-06-17 |
WO2001049309A2 (en) | 2001-07-12 |
AR027122A1 (es) | 2003-03-12 |
WO2001049309A3 (en) | 2002-02-28 |
CO5271671A1 (es) | 2003-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0014384A (pt) | Compostos para o tratamento da isquémia | |
ES2176600T3 (es) | Derivado de la propiofenona y procedimientos para su preparacion. | |
BR0200782A (pt) | Compostos para o tratamento da isquemia | |
PA8468401A1 (es) | Compuestos para el tratamiento de la isquemia | |
AR020055A1 (es) | Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma. | |
UY26724A1 (es) | Métodos y composiciones para tratar el virus de la hepatitis c | |
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
ES2145913T3 (es) | Inhibidores de metaloproteasas. | |
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
ATE218581T1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
DE69507185T2 (de) | Arzneimittel zur Behandlung von Osteoporose | |
EA200500804A1 (ru) | Топические противоинфекционные композиции | |
AR007582A1 (es) | Composicion para el lavado de la piel, procedimiento para prepararla y el uso de la misma para la fabricacion de medicamentos dado el caso, para eltratamiento cosmetico de la piel. | |
ATE333896T1 (de) | Vaskularisierungsinhibitoren | |
DE69116380D1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
ECSP003859A (es) | Composicion para el tratamiento de tejidos dañados | |
ES2173923T3 (es) | Procedimiento que permite inactivar un virus en presencia de un polieter y de un agente. | |
ECSP930933A (es) | Composicion farmaceutica y procedimiento para prepararla | |
BR0010983A (pt) | Preparações para a aplicação de agentes antiinflamatórios | |
AR022250A1 (es) | Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b. | |
DE69909747D1 (de) | Pharmazeutische zusammensetzung, enthaltend peg-asparaginase, für die behandlung von hiv infektionen | |
RS50805B (sr) | Upotreba fsh za lečenje neplodnosti | |
AR037496A1 (es) | Uso novedoso del 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y sus sales fisiologicamente aceptables | |
CO5271686A1 (es) | Nuevo uso de (r)-(-)-2-[5-(4-flurofenil)-3-piridilmetil- aminometil]-cromano y de sus sales aceptables para uso fisiologico | |
AR005730A1 (es) | Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato. |